Bloomia Holdings Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $13.1M
- Price
- $2.71
- % Change (Daily % change from the live per-ticker quote feed.)
- +0.37%
- Volume
- 1.6K
About
Bloomia Holdings, Inc., a specialty agricultural company, through its subsidiaries, focuses on making and managing its agricultural investments in the United States and internationally. It produces and sells fresh-cut tulips. The company was formerly known as Lendway, Inc. and changed its name to Bloomia Holdings, Inc. in January 2026. Bloomia Holdings, Inc. was incorporated in 1990 and is headquartered in Minneapolis, Minnesota.
Quick stats
Shares outstanding4.8M
Computed float3.8M
Float / shares79.0%
Key info
SectorCommunication Services
IndustryAdvertising Agencies
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0000875355
AI Summary
AI-generated1/2
majormixedearnings
Bloomia Holdings, Inc. Announces June 30, 2026 Financial Results
Bloomia Holdings (TULP) posted fiscal 2026 net revenue of $48.1 million, essentially flat versus $48.4 million a year ago, with a GAAP net loss attributable of $11.2 million, or $4.43 per diluted share, versus a $2.6 million loss in fiscal 2025.
The loss was driven by a one-time $13.2 million non-cash impairment ($11.1 million goodwill, $2.0 million intangibles) plus more than $2.5 million of excess production waste from an industry-wide mite treatment failure; adjusted EBITDA swung to a $0.5 million loss from +$2.0 million as bulb costs rose 21% and the Euro strengthened 6%.
The year's key highlight was balance-sheet repair: a rights offering raised $12.1 million gross ($5.0 million cash and $7.1 million of debt conversion, roughly 3 million shares at $4.05), letting the company retire over $19 million of debt for approximately $12 million, book a $7.0 million gain on settlement, and cut total debt 36% to $21.7 million.
For fiscal 2027, bulb prices are locked near historical averages — projected savings of greater than 20% on one of its largest expense categories — and a new mite control treatment is in place, supporting management's expectation of margin improvement.
Red flags
- $13.2M non-cash impairment (incl. $11.1M goodwill) nearly equals the company's $13.8M book equity — a writedown of acquisition-era value
- Adjusted EBITDA swung to a loss (-$0.5M) from +$2.0M, and cash used in operations was $4.0M vs $1.0M the prior year
- Industry-wide mite treatment failure caused over $2.5M of excess production waste concentrated in the highest-demand quarter
- Share count roughly tripled: ~3M new shares issued at $4.05 in the completed rights offering vs ~1.77M prior weighted basic shares
- Margin recovery depends on FY2027 locked bulb prices and a new mite treatment proving effective; input costs rose 21% and the Euro 6% in FY2026
- Revenue concentration risk: forward-looking factors cite concentration of Bloomia's historical revenue among a small number of customers